Anti-epileptics to get suicide warning in the EU
This article was originally published in Scrip
Executive Summary
The EU labels of antiepileptic medicines will be updated with information on the risk of suicidal thought and behaviour and the advice to monitor patients for suicidal ideation or behaviour during treatment, a recommendation which came just days after similar warnings required by the US FDA.